FORESITE CAPITAL MANAGEMENT IV, LLC

PrivateCIK: 1704132
Location

WEST HOLLYWOOD, CA

📋 What this filing means

FORESITE CAPITAL MANAGEMENT IV, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $290.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

6
Positions
$290.15M
Total AUM (reported)
9M
Total Shares

Allocation by class

TOTAL AUM$290.15M6 positions
COM$290.15M100.0%

Portfolio Concentration

Top 386.7%4–1013.3%TOP 10100.0%0%100%
Top 3$251.49M86.7%
4–10$38.66M13.3%

Top 3 weight

86.7%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 9M

Sole

Full voting authority

9M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:

Pharvaris N.V.

SOLE
COM
Shares4.78M
TypeSH
Market value$165.24M
56.95%
Sole
4.78M
Shared
0.00
None
0.00

CYTOKINETICS INC

SOLE
COM
Shares714.70K
TypeSH
Market value$60.88M
20.98%
Sole
714.70K
Shared
0.00
None
0.00

Eikon Therapeutics, Inc.

SOLE
COM
Shares1.94M
TypeSH
Market value$25.37M
8.74%
Sole
1.94M
Shared
0.00
None
0.00

Relay Therapeutics, Inc.

SOLE
COM
Shares1.25M
TypeSH
Market value$23.39M
8.06%
Sole
1.25M
Shared
0.00
None
0.00

Xenon Pharmaceuticals Inc.

SOLE
COM
Shares160K
TypeSH
Market value$9.66M
3.33%
Sole
160K
Shared
0.00
None
0.00

Crinetics Pharmaceuticals, Inc.

SOLE
COM
Shares150K
TypeSH
Market value$5.61M
1.93%
Sole
150K
Shared
0.00
None
0.00